Literature DB >> 21055713

Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure.

Jeffrey M Testani1, Brian D McCauley, Stephen E Kimmel, Richard P Shannon.   

Abstract

Worsening renal function (RF) and improved RF during the treatment of decompensated heart failure have traditionally been thought of as hemodynamically distinct events. We hypothesized that if the pulmonary artery catheter-derived measures are relevant in the evaluation of cardiorenal interactions, the comparison of patients with improved versus worsening RF should highlight any important hemodynamic differences. All subjects in the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness trial limited data set with admission and discharge creatinine values available were included (n = 401). No differences were found in the baseline, final, or change in pulmonary artery catheter-derived hemodynamic variables, inotrope and intravenous vasodilator use, or survival between patients with improved versus worsening RF (p = NS for all). Both groups were equally likely to be in the bottom quartile of cardiac index (p = 0.32), have a 25% improvement in cardiac index (p = 0.97), or have any worsening in cardiac index (p = 0.90). When patients with any significant change in renal function (positive or negative) were compared to those with stable renal function, strong associations between variables such as a reduced cardiac index (odds ratio 2.2, p = 0.02), increased intravenous inotrope and vasodilator use (odds ratio 2.9, p <0.001), and worsened all-cause mortality (hazard ratio 1.8, p = 0.01) became apparent. In contrast to traditionally held views, the patients with improved RF and those with worsening RF had similar hemodynamic parameters and outcomes. Combining these groups identified a hemodynamically compromised population with significantly worse survival than patients with stable renal function. In conclusion, the changes in renal function, regardless of the direction, likely identify a population with an advanced disease state and a poor prognosis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21055713      PMCID: PMC2997119          DOI: 10.1016/j.amjcard.2010.07.050

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

1.  Plasma expansion in surgical patients with high central venous pressure (CVP); the relationship of blood volume to hematocrit, CVP, pulmonary wedge pressure, and cardiorespiratory changes.

Authors:  S M Baek; G G Makabali; C W Bryan-Brown; J M Kusek; W C Shoemaker
Journal:  Surgery       Date:  1975-09       Impact factor: 3.982

2.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

3.  Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure.

Authors:  Mohammed W Akhter; Doron Aronson; Fahed Bitar; Salman Khan; Harpreet Singh; Rajinder P Singh; Andrew J Burger; Uri Elkayam
Journal:  Am J Cardiol       Date:  2004-10-01       Impact factor: 2.778

4.  Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions.

Authors:  Jeffrey M Testani; Brian D McCauley; Jennifer Chen; Michael Shumski; Richard P Shannon
Journal:  Cardiology       Date:  2010-08-03       Impact factor: 1.869

5.  Uric acid renal excretion and renal insufficiency in decompensated severe heart failure.

Authors:  Marcelo E Ochiai; Antonio C P Barretto; Múcio T Oliveira; Robinson T Munhoz; Paulo C Morgado; José A F Ramires
Journal:  Eur J Heart Fail       Date:  2005-06       Impact factor: 15.534

Review 6.  Assessment of indices of preload and volume responsiveness.

Authors:  Michael R Pinsky; Jean-Louise Teboul
Journal:  Curr Opin Crit Care       Date:  2005-06       Impact factor: 3.687

7.  Central venous pressure as a guide to volume expansion.

Authors:  J N Cohn
Journal:  Ann Intern Med       Date:  1967-06       Impact factor: 25.391

8.  The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

Authors:  D L Dries; D V Exner; M J Domanski; B Greenberg; L W Stevenson
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

9.  Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.

Authors:  Javed Butler; Daniel E Forman; William T Abraham; Stephen S Gottlieb; Evan Loh; Barry M Massie; Christopher M O'Connor; Michael W Rich; Lynne Warner Stevenson; Yongfei Wang; James B Young; Harlan M Krumholz
Journal:  Am Heart J       Date:  2004-02       Impact factor: 4.749

10.  Prediction of fluid responsiveness in patients during cardiac surgery.

Authors:  S Rex; S Brose; S Metzelder; R Hüneke; G Schälte; R Autschbach; R Rossaint; W Buhre
Journal:  Br J Anaesth       Date:  2004-10-01       Impact factor: 9.166

View more
  32 in total

1.  A patient with heart failure and worsening kidney function.

Authors:  Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 8.237

2.  Worsening Renal Function and Mortality in Heart Failure: Causality or Confounding?

Authors:  Jeffrey M Testani; Meredith A Brisco-Bacik
Journal:  Circ Heart Fail       Date:  2017-02       Impact factor: 8.790

3.  Is it AKI or nonrecovery of renal function that is important for long-term outcomes?

Authors:  Steven G Coca
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-10       Impact factor: 8.237

4.  Clinical impacts of changes of renal function during hospitalization depend on grades of renal dysfunction in acute decompensated heart failure.

Authors:  Seika Sai; Yoshihiro Seo; Daishi Nakagawa; Tomofumi Nakatsukasa; Naoto Kawamatsu; Akinori Sugano; Masayoshi Yamamoto; Yoshie Hamada-Harimura; Tomoko Machino-Ohtsuka; Isao Nishi; Tomoko Ishizu; Nobuyuki Ohte; Masaki Ieda
Journal:  Heart Vessels       Date:  2019-09-27       Impact factor: 2.037

Review 5.  Renal dysfunction and chronic mechanical circulatory support: from patient selection to long-term management and prognosis.

Authors:  Meredith A Brisco; Jeffrey M Testani; Jennifer L Cook
Journal:  Curr Opin Cardiol       Date:  2016-05       Impact factor: 2.161

6.  Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure.

Authors:  Matthew Griffin; Veena S Rao; James Fleming; Parinita Raghavendra; Jeffrey Turner; Devin Mahoney; Nicholas Wettersten; Alan Maisel; Juan B Ivey-Miranda; Lesley Inker; Wai Hong Wilson Tang; Francis Perry Wilson; Jeffrey M Testani
Journal:  Am J Cardiol       Date:  2019-09-06       Impact factor: 2.778

7.  Cardiorenal Syndrome Type 1: Renal Dysfunction in Acute Decompensated Heart Failure.

Authors:  Kurt W Prins; Thenappan Thenappan; Jeremy S Markowitz; Marc R Pritzker
Journal:  J Clin Outcomes Manag       Date:  2015-09

Review 8.  Novel renal biomarkers to assess cardiorenal syndrome.

Authors:  Meredith A Brisco; Jeffrey M Testani
Journal:  Curr Heart Fail Rep       Date:  2014-12

9.  Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure.

Authors:  Meredith A Brisco; Steven G Coca; Jennifer Chen; Anjali Tiku Owens; Brian D McCauley; Stephen E Kimmel; Jeffrey M Testani
Journal:  Circ Heart Fail       Date:  2013-01-16       Impact factor: 8.790

10.  Influence of age-related versus non-age-related renal dysfunction on survival in patients with left ventricular dysfunction.

Authors:  Jeffrey M Testani; Meredith A Brisco; Gang Han; Olga Laur; Alexander J Kula; Susan J Cheng; Wai Hong Wilson Tang; Chirag R Parikh
Journal:  Am J Cardiol       Date:  2013-10-03       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.